Diamyd Medical AB (publ) (DMYD-B.ST)
DMYD-B.ST Stock Price Chart
Explore Diamyd Medical AB (publ) interactive price chart. Choose custom timeframes to analyze DMYD-B.ST price movements and trends.
DMYD-B.ST Company Profile
Discover essential business fundamentals and corporate details for Diamyd Medical AB (publ) (DMYD-B.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 May 2013
Employees
30.00
Website
https://www.diamyd.comCEO
Ulf Hannelius MBA,
Description
Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase IIb clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.
DMYD-B.ST Financial Timeline
Browse a chronological timeline of Diamyd Medical AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Jun 2025
EPS came in at -kr 0.41 .
Earnings released on 9 Apr 2025
EPS came in at -kr 0.43 , while revenue for the quarter reached kr 86.00K .
Earnings released on 29 Jan 2025
EPS came in at -kr 0.35 , while revenue for the quarter reached kr 25.00K .
Earnings released on 9 Oct 2024
EPS came in at -kr 0.50 , while revenue for the quarter reached kr 18.00K .
Earnings released on 26 Jun 2024
EPS came in at -kr 0.41 , while revenue for the quarter reached kr 52.00K .
Earnings released on 27 Mar 2024
EPS came in at -kr 0.31 , while revenue for the quarter reached kr 26.00K .
Earnings released on 24 Jan 2024
EPS came in at -kr 0.37 , while revenue for the quarter reached kr 34.00K .
Earnings released on 11 Oct 2023
EPS came in at -kr 0.46 , while revenue for the quarter reached kr 74.00K .
Earnings released on 28 Jun 2023
EPS came in at -kr 0.27 , while revenue for the quarter reached kr 148.00K .
Stock split effective on 30 May 2023
Shares were split 128 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 5 Apr 2023
EPS came in at -kr 0.32 , while revenue for the quarter reached kr 113.00K .
Earnings released on 25 Jan 2023
EPS came in at -kr 0.42 , while revenue for the quarter reached kr 211.00K .
Earnings released on 5 Oct 2022
EPS came in at -kr 0.51 , while revenue for the quarter reached kr 116.00K .
Earnings released on 22 Jun 2022
EPS came in at -kr 0.22 , while revenue for the quarter reached kr 374.00K .
Earnings released on 30 Mar 2022
EPS came in at -kr 0.12 , while revenue for the quarter reached kr 231.00K .
Earnings released on 26 Jan 2022
EPS came in at -kr 0.52 , while revenue for the quarter reached kr 31.00K .
Earnings released on 13 Oct 2021
EPS came in at -kr 0.39 , while revenue for the quarter reached kr 51.00K .
Earnings released on 23 Jun 2021
EPS came in at -kr 0.46 , while revenue for the quarter reached kr 137.00K .
Earnings released on 26 Mar 2021
EPS came in at kr 0.21 , while revenue for the quarter reached kr 1.00K .
Earnings released on 20 Jan 2021
EPS came in at kr 1.48 , while revenue for the quarter reached kr 81.00K .
Earnings released on 7 Oct 2020
EPS came in at -kr 0.19 , while revenue for the quarter reached kr 78.00K .
DMYD-B.ST Stock Performance
Access detailed DMYD-B.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.